Intuitive Surgical, Inc. (ISRG) Average EV/EBITDA Ratio
The current ev/ebitda ratio for Intuitive Surgical, Inc. (ISRG) is 34.23x as of Tuesday, June 16, 2026, shown against its trailing averages.
Average EV/EBITDA Ratio Chart
ISRG EV/EBITDA Ratio Averages
EV/EBITDA RATIO CURRENT
34.23x
EV/EBITDA RATIO TTM
46.93x
EV/EBITDA RATIO 3Y
54.29x
EV/EBITDA RATIO 5Y
52.30x
EV/EBITDA RATIO 10Y
47.19x
EV/EBITDA RATIO 15Y
38.76x
EV/EBITDA RATIO 20Y
36.88x
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa